Motif Bio Share Discussion Threads

[scottdavid70] 18/10/2020 20:05

I will be pressing hard for a change in the low so that Complete Response Letters are published to shareholders in full. This is one area I am committed to change and will be using the WebCast of the 19th February 2019 where Lumsden says no clinical trials were indicated yet we ended up with a FULL PHASE lll trail not even for ABSSSI. This disparity for shareholders in terms of knowledge of whet they are still invested in needs to end. We need to level the playing field once and for all

[scottdavid70] 18/10/2020 20:01

So when Lumsden announced on the 11th November 2019 that Motif “has reached agreement with its former clinical research organisation to settle all obligations without further payment.” A saving of US$2.4 million we were all expected to understand this happened because the former clinical research organisation FAILED to get Iclaprim across the line. Of course, they didn’t actually say that did they because this is Motif we as shareholders aren’t given the full picture. We aren’t good enough for that are we? The liver toxicity issue wasn’t dealt with obviously now in hindsight.

On reviewing the Final Accounts and Interims did Lumsden stop his own salary based on his own failure to get Iclaprim passed which was his role like he argued the former research company shouldn’t get paid as they failed in their role?No. On reading the accounts it would appear he didn’t apply the same set of standards to his own situation did he? He has still taken a grotesque amount since February 2019. The hypocrisy is so vivid

[scottdavid70] 18/10/2020 09:47

Crucial to remember how much Lumsden and his cohorts pays themselves theses past 18 months despite failing to get Iclaprim approved or sold.

No hint of remorse or of taking no salary until a possible RTO was completed. Just carried on like they haven’t failed in their primary objective. Like they were owed a salary no matter what.

Investors took all the risk and the Directors have paid themselves handsomely this year despite stating they were under strict cost controls..

The publication of this story will have ramifications in the industry

[rapidlyprogressing] 18/10/2020 05:08

Unlucky mangola

[scottdavid70] 17/10/2020 15:23

In terms of the last question you can’t answer further ripping off long term shareholders who have invested their money in this company to be used to pay the wages of the people who have failed. Let’s try to figure a less obvious answer

[scottdavid70] 17/10/2020 15:15

Anyone here who can explain why there is a need for SIGNIFICANT DILUTION at this stage of the process for a RTO?

[scottdavid70] 17/10/2020 15:14

Anyone who is actually invested here think Lumsden deserves a Bonus?

[scottdavid70] 17/10/2020 15:11

By the way percectstorm you certainly aren’t invested here given your recent posts but nice try

[scottdavid70] 17/10/2020 15:10

Haha perfectstorm...30 companies want to do a deal. I think even these clowns can do a deal to re-list but at what price and what dilution to feed their greedy grubby hands. That’s what everyone is monitoring here and if there is any more of what unfolded in 2019 then there is and will be SIGNIFICANT (as they like that word) recourse to settle a few issues...

[perfectstorm] 17/10/2020 14:59

I lost a ton of money here, I made it back recently on ALBA. You win some, you lose some. That is the meaning of life, the universe and everything. Nobody here will see their money in this stock. Trade or invest in something else.

[scottdavid70] 17/10/2020 10:41

Just had an AMAZING THOUGHT:

Maybe the potential SIGNIFICANT DILUTION of the long term suffering shareholders is to pay GRAHAM LUMSDEN his BONUS????

Where do I sign up for that? Please can I? What a splendid idea and fully deserved of course

[scottdavid70] 17/10/2020 10:31

Pretty telling that when I look up Lumsdens LinkedIn in page as I do every day. He hasn’t been recruited by anyo other company since the catastrophe and carnage that unfolded here. Maybe it wasn’t in most business and recruitment agencies eyes all part of a cunning plan that had caused chaos to hard working people’s investments? Maybe even not worthy of a BONUS peut-être?

[scottdavid70] 17/10/2020 10:16

The $1 billion AMR fund is now active for acquiring antibiotics and developing them. If Iclaprim is of no interest can Motif actually justify a BONUS to Lumsden if $100,000?

Pretty hard too even with this mob at the helm

It will cost approximately $40 million and a couple of years to get it back in front of the FDA. If the boffins running the AMR fund don’t think Iclaprim is worth that paltry investment and minuscule timeframe for a antibiotic then we had a puffin at the helm all these years..

[lithological heterogeneities] 16/10/2020 19:47

Not long now

[scottdavid70] 16/10/2020 10:14

Imagine this scenario:

More than a BILLION shares in issue potentially and LUMSDEN gets a BONUS for this happening!!!

I weep...

[scottdavid70] 16/10/2020 10:12

Why there is a need for a potential and significant capital raise is beyond comprehension and stinks of being grotesque.

It will be almost impossible to justify

[scottdavid70] 16/10/2020 10:10

Companies House filing:

Directors allowed now to issue up to one half of the allotted shares in issue. They had better offer them to long term shareholders first is all I can say

[scottdavid70] 15/10/2020 14:41

I repeat:

One thing to remember investors is that if the BOD is acting in your best interests they won’t have a problem with you asking why their is potential for SIGNIFICANT DILUTION because they are looking after your best interests right? That is THEIR lawfully designated jobs. So fire away with your enquiries. Phone or email NOW

[scottdavid70] 15/10/2020 14:40

They may not care about me the real investors here but they will care their investment is being looked after as it should be legally and dutifully by the BOD in shareholders best interests

[rapidlyprogressing] 15/10/2020 14:24

Nobody cares. You aren't a real man